Trials / Completed
CompletedNCT02795117
Comparative Safety and Efficacy of Two Treatments in the Treatment of Inflammatory Lesions of Rosacea
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 486 (actual)
- Sponsor
- Padagis LLC · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare the safety and efficacy of Perrigo's product to an FDA approved product for the treatment of inflammatory lesions rosacea
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ivermectin | |
| DRUG | Ivermectin (reference) | |
| DRUG | Placebo |
Timeline
- Start date
- 2016-05-01
- Primary completion
- 2017-02-01
- Completion
- 2017-02-01
- First posted
- 2016-06-09
- Last updated
- 2021-11-02
- Results posted
- 2021-01-05
Source: ClinicalTrials.gov record NCT02795117. Inclusion in this directory is not an endorsement.